Tuberculosis News and Research

Latest Tuberculosis News and Research

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Data from a retrospective pooled analysis of eight phase III trials (two 18-week and six 24-week) of linagliptin 5 mg once-daily, showed reductions from baseline A1c at 18 (eight trials) and 24 (six trials) weeks compared to placebo in African-American adults with type 2 diabetes (T2D),

16 May 2014

WHO's annual statistics report shows global life expectancy continues to increase

People everywhere are living longer, according to the "World Health Statistics 2014" published today by WHO. Based on global averages, a girl who was born in 2012 can expect to live to around 73 years, and a boy to the age of 68.

15 May 2014

Findings from 1918 Flu Pandemic research could help improve current health policies

The 1918 Flu Pandemic infected over 500 million people, killing at least 50 million. Now, a researcher at the University of Missouri has analyzed the pandemic in two remote regions of North America, finding that despite their geographical divide, both regions had environmental, nutritional and economic factors that influenced morbidity during the pandemic.

15 May 2014

Researchers find TB infection in lungs may decrease diversity of gut bacteria in mice

Johns Hopkins researchers have found evidence in mice that a tuberculosis (TB) infection in the lungs triggers immune system signaling to the gut that temporarily decreases the diversity of bacteria in that part of the digestive tract.

14 May 2014

Highlights: Mass. death rate drops after universal coverage; Calif. immigrant licensing; Calif. offenders mental health treatment

The mortality rate in Massachusetts declined substantially in the four years after the state enacted a law in 2006 mandating universal health care coverage, providing the model for the Affordable Care Act.

13 May 2014

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Janssen R&D Ireland Ltd. (Janssen) today announced that it has expanded its collaboration with the International Partnership for Microbicides (IPM) for the development and delivery of dapivirine (TMC120) for the prevention of HIV.

8 May 2014

Inflammatory pneumococcal response differs by age

The composition of inflammatory lung infiltrate in people with pneumonia caused by Streptococcus pneumoniae differs by age, an in-situ study reveals.

6 May 2014

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

UCB announced today results from the PRECiSE 3 7-year open label extension clinical trial of Cimzia (certolizumab pegol), the longest continuous trial of an anti-TNF therapy evaluating long-term safety in Crohn's disease.

6 May 2014

New hope for improved diagnosis of children with TB

A distinctive genetic 'signature' found in the blood of children with tuberculosis (TB) offers new hope for improved diagnosis of the disease.

2 May 2014

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.

30 Apr 2014

Mother's diet before conception can permanently affect how her child's genes function

A mother's diet before conception can permanently affect how her child's genes function, according to a study published in Nature Communications.

30 Apr 2014

The rising incidence of multi-drug resistant TB: an interview with Dr Myriam Haxaire-Theeuwes, Compound Development Team Leader, Janssen

MDR-TB is on the rise in a number of regions in the world, because progress towards targets for diagnosis and treatment of multidrug-resistant TB (MDR-TB) is far off-track.

29 Apr 2014

TB Alliance advances first-ever TB drug regimen to global Phase 3 clinical trial

Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both drug-sensitive and some forms of multi-drug resistant tuberculosis (TB) to a global Phase 3 clinical trial.

25 Apr 2014

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Pfizer Inc. announced today top-line results from two pivotal Phase 3 trials from the Oral treatment Psoriasis Trials (OPT) Program, OPT Pivotal #1 (A3921078) and OPT Pivotal #2 (A3921079), evaluating the efficacy and safety of tofacitinib, an oral Janus kinase (JAK) inhibitor, the first in a new class of medicines being investigated for the treatment of moderate-to-severe plaque psoriasis.

23 Apr 2014

Researchers investigate impact of nutrition in resource-poor regions on infant brain development

Brain activity of babies in developing countries could be monitored from birth to reveal the first signs of cognitive dysfunction, using a new technique piloted by a London-based university collaboration.

22 Apr 2014

Automated diagnostic technologies redefine infectious diseases

The diagnostics market for infectious diseases such as tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis C virus and human papilloma virus is expanding, giving rise to commercial opportunities especially in the developing economies of Asia, Africa and Latin America.

22 Apr 2014

New device uses space-tested concept of capillary flow to diagnose infectious diseases

A new medical-testing device is being prepped to enter the battle against infectious disease. This instrument could improve diagnosis of certain diseases in remote areas, thanks in part to knowledge gained from a series of investigations aboard the International Space Station on the behavior of liquids. The device uses the space-tested concept of capillary flow to diagnose infectious diseases such as HIV/AIDS and tuberculosis.

20 Apr 2014

Drug used to treat TB may also act against various infections, says study

A drug under clinical trials to treat tuberculosis could be the basis for a class of broad-spectrum drugs that act against various bacteria, fungal infections and parasites, yet evade resistance, according to a study by University of Illinois chemists and collaborators.

18 Apr 2014

Deaths from viral Hepatitis B and C exceed deaths caused by HIV/AIDS

Deaths from viral Hepatitis B and C have surpassed HIV/AIDS in many countries, including Australia and in Western Europe, according to an analysis of the 2010 Global Burden of Disease study.

18 Apr 2014

Researchers examine effects of introducing rapid diagnostic tests for malaria in Africa

Researchers from the Cochrane Infectious Diseases Group conducted a review of the effects of introducing rapid diagnostic tests (RDTs) for diagnosing malaria in primary healthcare settings in Africa where laboratory services are unavailable.

17 Apr 2014

Tuberculosis News and Research

Latest Tuberculosis News and Research

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

WHO's annual statistics report shows global life expectancy continues to increase

Findings from 1918 Flu Pandemic research could help improve current health policies

Researchers find TB infection in lungs may decrease diversity of gut bacteria in mice

Highlights: Mass. death rate drops after universal coverage; Calif. immigrant licensing; Calif. offenders mental health treatment

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Inflammatory pneumococcal response differs by age

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

New hope for improved diagnosis of children with TB

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Mother's diet before conception can permanently affect how her child's genes function

The rising incidence of multi-drug resistant TB: an interview with Dr Myriam Haxaire-Theeuwes, Compound Development Team Leader, Janssen

TB Alliance advances first-ever TB drug regimen to global Phase 3 clinical trial

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Researchers investigate impact of nutrition in resource-poor regions on infant brain development

Automated diagnostic technologies redefine infectious diseases

New device uses space-tested concept of capillary flow to diagnose infectious diseases

Drug used to treat TB may also act against various infections, says study

Deaths from viral Hepatitis B and C exceed deaths caused by HIV/AIDS

Researchers examine effects of introducing rapid diagnostic tests for malaria in Africa

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in